Real-world use of pembrolizumab in early-stage triple-negative breast cancer: Data from the French Early Access Program. // The Breast. – URL: https://www.sciencedirect.com/science/article/pii/S0960977626002584?dgcid=rss_sd_all
Real-world use of pembrolizumab in early-stage triple-negative breast cancer: Data from the French Early Access Program. The Breast. https://www.sciencedirect.com/science/article/pii/S0960977626002584?dgcid=rss_sd_all
“Real-world use of pembrolizumab in early-stage triple-negative breast cancer: Data from the French Early Access Program.” The Breast.
@article{article67635,
title = {Real-world use of pembrolizumab in early-stage triple-negative breast cancer: Data from the French Early Access Program},
journal = {The Breast},
url = {https://www.sciencedirect.com/science/article/pii/S0960977626002584?dgcid=rss_sd_all}
}